Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
December 21, 2021
Patent Application Number
16250211
Date Filed
January 17, 2019
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present disclosure relates to compositions comprising inhibitors of human histone methyltransferase EZH2 and one or more other therapeutic agents, particularly anticancer agents such as prednisone, and methods of combination therapy for administering to subjects in need thereof for the treatment of cancer.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
